Giulia C. Kennedy - Jun 4, 2021 Form 4 Insider Report for VERACYTE, INC. (VCYT)

Role
Chief Scientific & Med Officer
Signature
/s/ Jane Alley as attorney-in-fact
Stock symbol
VCYT
Transactions as of
Jun 4, 2021
Transactions value $
-$212,380
Form type
4
Date filed
6/8/2021, 04:38 PM
Previous filing
Jun 4, 2021
Next filing
Jun 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCYT Common Stock Options Exercise $26.3K +4.41K +8.34% $5.98 57.2K Jun 4, 2021 Direct F1
transaction VCYT Common Stock Options Exercise $75.8K +3.75K +6.55% $20.21 61K Jun 4, 2021 Direct F1
transaction VCYT Common Stock Sale -$50.2K -1.51K -2.47% $33.28 59.5K Jun 4, 2021 Direct F1, F2
transaction VCYT Common Stock Sale -$89.3K -2.6K -4.36% $34.39 56.9K Jun 4, 2021 Direct F1, F3
transaction VCYT Common Stock Sale -$175K -4.98K -8.76% $35.17 51.9K Jun 4, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCYT Stock Option (right to buy) Options Exercise $0 -4.41K -25% $0.00 13.2K Jun 4, 2021 Common Stock 4.41K $5.98 Direct F5
transaction VCYT Stock Option (right to buy) Options Exercise $0 -3.75K -12.5% $0.00 26.3K Jun 4, 2021 Common Stock 3.75K $20.21 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 12, 2020.
F2 Represents weighted average sales price. Sale prices for the transactions range from $32.92 to $33.68. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3 Represents weighted average sales price. Sale prices for the transactions range from $33.93 to $34.93. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F4 Represents weighted average sales price. Sale prices for the transactions range from $34.95 to $35.27. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F5 The option becomes exercisable as to 25% of the shares on March 2, 2019, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter
F6 The option becomes exercisable as to 25% of the shares on February 28, 2020, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter.